(Q81816379)

English

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

scientific article published on 01 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

2

object named as

Saliba RM

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Richard E Champlin

8

object named as

Champlin RE

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

6

object named as

Giralt S

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Shahjahan M

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Estey EH

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Couriel D

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Andersson B

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

De Lima M

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 July 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

157-162

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15937511%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705011

0 references

Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic transplantation after failure of first autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Individual Comparisons by Ranking Methods

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81816379&oldid=1809620319"